Comparison of Effectiveness of Methadone and Two Sublingual Formulations of Buprenorphine on Maintenance Treatment Outcomes Experimental and Clinical Psychopharmacology This study sought to compare the effectiveness of the 3 most commonly prescribed maintenance medications in the United States indicated for the treatment of opioid dependence in reducing illicit drug use and retaining patients in treatment. The 6-month prevalence rates of positive urinalysis drug screen findings for both opioids and nonopioid substances were similar across medication groups...
Improving Trauma and Behavioral Health Services SAMHSA Treatment Improvement Protocol (TIP) 57, Trauma-Informed Care in Behavioral Health Services, provides evidence-based and best practice information for behavioral health practitioners and administrators working with people who have experienced trauma.
TREAT Act Write-Up Available Senate.gov Last month, ASAM declared its support for The Recovery Enhancement for Addiction Treatment (TREAT) Act. This bill would lift the buprenorphine prescribing limit for addiction physician specialists and non-specialist providers. As it stands, the prescribing limit inhibits treatment for many people suffering from the chronic disease of addiction. Now, read the entire Act proposed.
Maternal Pre-Pregnancy Risk Drinking and Toddler Behavior Problems: the Norwegian Mother and Child Cohort Study European Child & Adolescent Psychiatry Maternal risk drinking may be a risk factor for child behavior problems even if the mother has discontinued this behavior. Associations were analyzed with multivariate logistic regression, controlling for pre and postnatal alcohol use, as well as other relevant covariates. Pre-pregnancy risk drinking was associated with child behavior problems at 18 and 36 months, even after controlling for pre and postnatal alcohol use...
Effect of Prenatal Exposure to Tobacco Smoke on Inhibitory Control: Neuroimaging Results from a 25-Year Prospective Study JAMA Psychiatry There is accumulating evidence relating maternal smoking during pregnancy to attention-deficit/hyperactivity disorder (ADHD) without elucidating specific mechanisms. The findings from this study point to a functional involvement of prenatal exposure to tobacco smoke in neural alterations similar to ADHD, which underlines the importance of smoking prevention treatments.
Deficits in Behavioral Inhibition in Substance Abuse and Addiction: A Meta-Analysis Drug and Alcohol Dependence Deficits in behavioral inhibitory control are attracting increasing attention as a factor behind the development and maintenance of substance dependence. However, evidence for such a deficit is varied in the literature. Here, the authors synthesized published results to determine whether inhibitory ability is reliably impaired in substance users compared to controls.
Costs of Care for Persons with Opioid Dependence in Commercial Integrated Health Systems Addiction Science & Clinical Practice When used in general medical practices, buprenorphine is an effective treatment for opioid dependence, yet little is known about how use of buprenorphine affects the utilization and cost of health care in commercial health systems.
Risk Behaviors Among Substance Use Disorder Treatment Seekers with and without Adult ADHD Symptoms Drug and Alcohol Dependence Impulsivity and consequent risk-taking are features of both Attention Deficit Hyperactivity Disorder (ADHD) and substance use disorder (SUD). The findings in this study suggest that the risk-taking behavior that is common among people with SUD is further increased among those with comorbid ADHD symptoms, particularly with respect to dangerous driving practices...
A Microbial Biomanufacturing Platform for Natural and Semisynthetic Opioids Chemical Biology Opiates and related molecules are medically essential, but their production via field cultivation of opium poppy Papaver somniferum leads to supply inefficiencies and insecurity. As an alternative production strategy, the authors developed baker's yeast Saccharomyces cerevisiae as a microbial host for the transformation of opiates.
CVS Demonstrates Dedication to Consumer Health ASAM In February, ASAM congratulated CVS on its decision to "quit" sales of cigarettes by October 1, 2014. Now, CVS has pulled cigarettes from its shelves nearly a month early, earning the respect of medical professionals throughout the U.S.
Richard G. Soper, MD, JD, MS, FASAM, Editor-in-Chief, ASAM Weekly
Brendan McEntee, Managing Editor & ASAM Publications Manager, 301.656.3920 ext. 110
Emily McMartin, New Media and Content Coordinator
Jennifer Strauser, Account and Customer Service Manager, Highwater Partners, 407.221.4292 AdvertiseView media kit
The views and positions of any content published in ASAM Weekly are not necessarily endorsed by ASAM nor a reflection of ASAM's beliefs and policies. The features are presented as a summary of the contemporary issues being represented and expressed in scientific, governmental, commercial, and media sources across the specialty field of addiction medicine. Contact ASAM Weekly with any comments or feedback.